Related Experiment Video
Updated: Dec 12, 2025

Author Spotlight: Deciphering Coagulation Disorders in Traumatic Brain Injury Patients
Published on: August 4, 2023
Evaluation of coagulation status using viscoelastic testing in intensive care patients with coronavirus disease 2019
Luke Wallace Collett1, Samuel Gluck1, Richard Michael Strickland1
1Intensive Care Unit, Royal Adelaide Hospital, Adelaide, SA, Australia; School of Acute Medicine, University of Adelaide, Adelaide, SA, Australia.
Insights
Critically ill COVID-19 patients show a hypercoagulable state, not detected by standard tests. Viscoelastic testing reveals supranormal clot firmness and minimal lysis, indicating a need for further research into anticoagulation strategies.
Area of Science:
- Critical Care Medicine
- Hematology
- Infectious Diseases
Background:
- Coronavirus Disease-19 (COVID-19) is linked to significant thrombosis.
- The exact pathophysiology of COVID-19-associated thrombosis remains unclear.
- Viscoelastic testing offers a method to characterize hypercoagulable states beyond conventional assays.
Purpose of the Study:
- To evaluate the coagulation status in critically ill adults with COVID-19-associated respiratory failure using viscoelastic testing.
- To compare viscoelastic findings with conventional coagulation markers.
Main Methods:
- Single-center observational point prevalence cohort study.
- Inclusion of adult patients with COVID-19-associated respiratory failure requiring intensive care unit (ICU) respiratory support.
- Coagulation status assessed using rotational thromboelastometry (ROTEM®) alongside laboratory markers.
Main Results:
- All six included patients demonstrated supranormal clot amplitude (A10) and clot firmness on ROTEM®.
- Five patients showed supranormal firmness across all ROTEM® pathways.
- Minimal clot lysis was observed in all patients, with elevated fibrinogen and D-dimer levels despite normal routine coagulation markers.
Conclusions:
- Critically ill COVID-19 patients exhibit a hypercoagulable state not evident through conventional coagulation tests.
- Key findings include supranormal clot firmness, minimal fibrinolysis, and hyperfibrinogenaemia.
- Further investigation is needed into the underlying pathophysiology and optimal anticoagulation strategies for this condition.
Background:
Coronavirus Disease-19 (COVID-19) is associated with a high rate of thrombosis, the pathophysiology of which is not well defined. Viscoelastic testing may identify and characterise hypercoagulable states which are not apparent using conventional coagulation assays.
Objectives:
The objective of this study was to undertake viscoelastic evaluation of the coagulation state in critically ill adults with COVID-19-associated respiratory failure METHODS: This was a single-centre observational point prevalence cohort study of adults with COVID-19-associated respiratory failure requiring respiratory support in the intensive care unit. Coagulation status was evaluated using rotational thromboelastometry (ROTEM®) in conjunction with laboratory markers of coagulation.
Results:
Six patients fulfilled inclusion criteria. Each patient had one ROTEM® performed. All patients had supranormal clot amplitude at 10 min (A10) and supranormal clot firmness (maximal clot firmness) measured in at least one ROTEM® pathway, and five were supranormal on all pathways. Minimal clot lysis was present on all analyses. Fibrinogen and D-dimer were elevated and routine markers of coagulation within normal ranges in all patients.
Conclusion:
Patients with COVID-19-associated respiratory failure admitted to the intensive care unit exhibit a hypercoagulable state which is not appreciable on conventional tests of coagulation. Supranormal clot firmness, minimal fibrinolysis, and hyperfibrinogenaemia are key findings. Further research is required into the pathophysiology of this hypercoagulable state, as well as the harms and benefits of different anticoagulation strategies.
Related Concept Videos
Coagulation
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
Coagulation
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Acute Coronary Syndrome III: Diagnostic Studies
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Varicose Veins II: Diagnostic Studies and Interprofessional Care

